OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Risk factors for poor COVID-19 outcomes in patients with psychiatric disorders
Wan‐Ju Cheng, Hong-Mo Shih, Kuan‐Pin Su, et al.
Brain Behavior and Immunity (2023) Vol. 114, pp. 255-261
Closed Access | Times Cited: 15
Wan‐Ju Cheng, Hong-Mo Shih, Kuan‐Pin Su, et al.
Brain Behavior and Immunity (2023) Vol. 114, pp. 255-261
Closed Access | Times Cited: 15
Showing 15 citing articles:
Antipsychotic exposure and infection risk in people with schizophrenia spectrum disorders during the COVID-19 pandemic: a Danish nationwide registry study
Vardan Nersesjan, Rune Haubo Bojesen Christensen, Elisabeth Andersen, et al.
The Lancet Psychiatry (2024) Vol. 11, Iss. 10, pp. 796-806
Closed Access | Times Cited: 5
Vardan Nersesjan, Rune Haubo Bojesen Christensen, Elisabeth Andersen, et al.
The Lancet Psychiatry (2024) Vol. 11, Iss. 10, pp. 796-806
Closed Access | Times Cited: 5
Neuropsychiatric Manifestations of Long COVID-19: A Narrative Review of Clinical Aspects and Therapeutic Approaches
Olga Adriana Căliman-Sturdza, Roxana Gheorghiţă, Andrei Lobiuc
Life (2025) Vol. 15, Iss. 3, pp. 439-439
Open Access
Olga Adriana Căliman-Sturdza, Roxana Gheorghiţă, Andrei Lobiuc
Life (2025) Vol. 15, Iss. 3, pp. 439-439
Open Access
Effectiveness of molnupiravir for treating COVID-19 in patients with psychiatric disorders
Ting-Hui Liu, Hsuan-Yi Liao, Chih‐Cheng Chang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 2
Ting-Hui Liu, Hsuan-Yi Liao, Chih‐Cheng Chang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 2
Risk of COVID‐19 Hospitalization and Protection Associated With mRNA Vaccination Among US Adults With Psychiatric Disorders
Matthew E. Levy, Duck‐Hye Yang, Margaret M. Dunne, et al.
Influenza and Other Respiratory Viruses (2024) Vol. 18, Iss. 3
Open Access | Times Cited: 1
Matthew E. Levy, Duck‐Hye Yang, Margaret M. Dunne, et al.
Influenza and Other Respiratory Viruses (2024) Vol. 18, Iss. 3
Open Access | Times Cited: 1
Outpatient Antipsychotic Use and Severe COVID-19: Avoiding the Impact of Age in a Real-World Data Study
Samuel Pintos‐Rodríguez, Irene Visos‐Varela, Almudena Rodríguez-Fernández, et al.
The International Journal of Neuropsychopharmacology (2024) Vol. 27, Iss. 4
Open Access | Times Cited: 1
Samuel Pintos‐Rodríguez, Irene Visos‐Varela, Almudena Rodríguez-Fernández, et al.
The International Journal of Neuropsychopharmacology (2024) Vol. 27, Iss. 4
Open Access | Times Cited: 1
Predictive Factors for Poor Outcomes Associated with COVID-19 in a Retrospective Cohort of Myasthenia Gravis Patients
Zhuajin Bi, Huajie Gao, Jing Lin, et al.
Journal of Inflammation Research (2024) Vol. Volume 17, pp. 5807-5820
Open Access | Times Cited: 1
Zhuajin Bi, Huajie Gao, Jing Lin, et al.
Journal of Inflammation Research (2024) Vol. Volume 17, pp. 5807-5820
Open Access | Times Cited: 1
Effectiveness of COVID-19 Vaccines in People with Severe Mental Illness: A Systematic Review and Meta-Analysis
Wen Dang, I. R. Long, Zhao Yi-wei, et al.
Vaccines (2024) Vol. 12, Iss. 9, pp. 1064-1064
Open Access | Times Cited: 1
Wen Dang, I. R. Long, Zhao Yi-wei, et al.
Vaccines (2024) Vol. 12, Iss. 9, pp. 1064-1064
Open Access | Times Cited: 1
Evaluation of Inflammatory Markers in Patients with COVID-19 Combined with Type 2 Diabetes Mellitus
Jingjing Li, Yu Zhang, Rui Wu, et al.
Risk Management and Healthcare Policy (2024) Vol. Volume 17, pp. 2535-2545
Open Access | Times Cited: 1
Jingjing Li, Yu Zhang, Rui Wu, et al.
Risk Management and Healthcare Policy (2024) Vol. Volume 17, pp. 2535-2545
Open Access | Times Cited: 1
ВПЛИВ КОРОНАВІРУСНОЇ ХВОРОБИ COVID-19 НА ПЕРЕБІГ ПСИХІЧНИХ РОЗЛАДІВ У ПАЦІЄНТІВ З ПСИХІЧНИМИ ПОРУШЕННЯМИ В АНАМНЕЗІ
Natalia Maruta, Viktoriya Fedchenko, Т В Панько, et al.
Здобутки клінічної і експериментальної медицини (2024), Iss. 3, pp. 53-62
Closed Access
Natalia Maruta, Viktoriya Fedchenko, Т В Панько, et al.
Здобутки клінічної і експериментальної медицини (2024), Iss. 3, pp. 53-62
Closed Access
Risk factors for psychiatric disorders following traumatic brain injury: a multivariate logistic regression analysis
Hanyu Liu, Yi Tao
Frontiers in Psychiatry (2024) Vol. 15
Open Access
Hanyu Liu, Yi Tao
Frontiers in Psychiatry (2024) Vol. 15
Open Access
Pathopsychological features of emotional and cognitive disorders in the structure of post-COVID syndrome
Hanna Kozhyna, I.V. Leshchyna, О.V. Samoilova, et al.
Medicine Today and Tomorrow (2024) Vol. 93, Iss. 4
Closed Access
Hanna Kozhyna, I.V. Leshchyna, О.V. Samoilova, et al.
Medicine Today and Tomorrow (2024) Vol. 93, Iss. 4
Closed Access
CLINICAL PHENOMENOLOGY AND MANAGEMENT OF MENTAL DISORDERS IN INDIVIDUALS WHO HAVE EXPERIENCED COVID-19
Herman Berezhnyi, Kateryna Zelenska, Наnna Kozhyna, et al.
Ukrains kyi Visnyk Psykhonevrolohii (2024), Iss. Volume 32, issue 4 (121), 2024, pp. 11-13
Closed Access
Herman Berezhnyi, Kateryna Zelenska, Наnna Kozhyna, et al.
Ukrains kyi Visnyk Psykhonevrolohii (2024), Iss. Volume 32, issue 4 (121), 2024, pp. 11-13
Closed Access
Comment on Cheng et al.’s “Risk factors for poor COVID-19 outcomes in patients with psychiatric disorders”
Wei‐Min Chu, Hsin‐En Ho, James Cheng‐Chung Wei
Brain Behavior and Immunity (2023) Vol. 115, pp. 333-334
Closed Access
Wei‐Min Chu, Hsin‐En Ho, James Cheng‐Chung Wei
Brain Behavior and Immunity (2023) Vol. 115, pp. 333-334
Closed Access
Ferritin levels as a potential predictive clinical marker: Risk factors for poor COVID-19 outcomes in patients with psychiatric disorders (Brain. Behav. Immun. 2023 Aug 28:114:255–261. doi: 10.1016/j.bbi.2023.08.024)
Tieh‐Cheng Fu, Juei-Chao Chen, Ching‐Mao Chang
Brain Behavior and Immunity (2023) Vol. 115, pp. 432-433
Closed Access
Tieh‐Cheng Fu, Juei-Chao Chen, Ching‐Mao Chang
Brain Behavior and Immunity (2023) Vol. 115, pp. 432-433
Closed Access
Reply to letter by Dr. Fu and Dr. Chu: Risk factors for poor COVID-19 outcomes in patients with psychiatric disorders
Wan‐Ju Cheng, Hong-Mo Shih, Kuan‐Pin Su, et al.
Brain Behavior and Immunity (2023) Vol. 115, pp. 448-449
Closed Access
Wan‐Ju Cheng, Hong-Mo Shih, Kuan‐Pin Su, et al.
Brain Behavior and Immunity (2023) Vol. 115, pp. 448-449
Closed Access
